Le Lézard
Classified in: Transportation, Science and technology, Business
Subject: ACC

Unipart welcomes £4.5 billion government investment in UK manufacturing


OXFORD, England, Nov. 17, 2023 /PRNewswire/ -- Unipart, global supply chain and performance improvement technologies partner, has welcomed the Government announcement of a £4.5 billion investment in UK strategic manufacturing sectors.

The government announced today (17 November) the funding will be available from 2025 for five years, providing industry with longer term certainty about their investments.

Over £2 billion has been earmarked for the automotive industry and £975 million for aerospace, supporting the manufacturing, supply chain and development of zero emission vehicles, and investment in energy efficient and zero-carbon aircraft equipment. 

John Neill, Executive Chairman of Unipart Group, said: "We welcome the Government's commitment to advanced manufacturing and the recognition of the strategic importance of the automotive industry to the UK.  As an independent management and employee-owned company, Unipart has seen the strategic benefit from investing in developing performance improvement technologies for our global clients across a range of industries including automotive. The government's investment strategy will enhance opportunities for companies like ours to continue that vital innovation."

With a strong heritage in the automotive sector, Unipart has grown into a supply chain and performance improvement technologies partner in a wide range of markets including rail, aerospace, healthcare and technology.

Media contact:
Alistair Drummond,
[email protected],
tel: 01865 383068

Photo - https://mma.prnewswire.com/media/2280777/Unipart.jpg


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...



News published on and distributed by: